» Articles » PMID: 24393388

Procalcitonin Testing for Diagnosis and Short-term Prognosis in Bacterial Infection Complicated by Congestive Heart Failure: a Multicenter Analysis of 4,698 Cases

Overview
Journal Crit Care
Specialty Critical Care
Date 2014 Jan 8
PMID 24393388
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Procalcitonin (PCT) is a biomarker for the clinical diagnosis of bacterial infection that is more specific and earlier than fever, changes in white blood cell count, and blood cultures. Congestive heart failure is an important cause of endotoxin resorption from the intestine, which significantly increases PCT expression in noninfected patients with heart failure. The diagnostic performance and cut-off value of PCT in patients with bacterial infection complicated by congestive heart failure needs to be confirmed.

Methods: A total of 4,698 cases from different cities in China, including those with different classes of congestive heart failure, bacterial infection, bacterial infection complicated by heart failure and healthy individuals, were chosen for the diagnostic value analysis of PCT and screening candidate predictors of mortality in subjects with bacterial infection complicated by congestive heart failure.

Results: Patients with simple heart failure had significantly higher PCT levels than normal controls (P < 0.01), whereas patients with bacterial infection complicated by congestive heart failure had significantly higher PCT levels than those with simple infection (P < 0.01). Although it was useful for the diagnosis of infection (area under the receiver operating characteristic curve >80%), the positive predictive value of PCT decreased significantly with increasing severity of heart failure (P < 0.05), and the cut-off value of PCT concentrations for infection complicated by classes II, III and IV heart failure were 0.086, 0.192 and 0.657 μg/L, respectively. Heart failure degree, PCT level, and age were the candidate predictors of mortality in patients with bacterial infection complicated by congestive heart failure.

Conclusions: These data suggest that complicated heart failure elevates the PCT level in patients with bacterial infection. Thus, the results of the PCT test must be analyzed correctly in consideration of the severity of heart failure. Close attention should be paid to cardiac function and PCT expression in aged patients with infection complicated by congestive heart failure.

Citing Articles

Association between red blood cell distribution width-to-platelet ratio and post-discharge readmission rate in patients with heart failure: A retrospective cohort study.

Lin S, Mao X, He W, Zhan Q Heliyon. 2024; 10(4):e26549.

PMID: 38434056 PMC: 10906436. DOI: 10.1016/j.heliyon.2024.e26549.


Infection as an under-recognized precipitant of acute heart failure: prognostic and therapeutic implications.

Bezati S, Velliou M, Ventoulis I, Simitsis P, Parissis J, Polyzogopoulou E Heart Fail Rev. 2023; 28(4):893-904.

PMID: 36897491 PMC: 9999079. DOI: 10.1007/s10741-023-10303-8.


A retrospective cohort study of the effect of rapid versus delayed-result procalcitonin testing on antibiotic use at a community hospital.

Anderson E, White B, Goodwin E, Alkhateeb F, White C Int J Clin Pharm. 2022; 44(5):1188-1194.

PMID: 35947325 DOI: 10.1007/s11096-022-01462-z.


Low-Level Elevations of Procalcitonin Are Associated with Increased Mortality in Acute Heart Failure Patients, Independent of Concomitant Infection.

Darche F, Biener M, Muller-Hennessen M, Rivinius R, Stoyanov K, Milles B Life (Basel). 2021; 11(12).

PMID: 34947960 PMC: 8706732. DOI: 10.3390/life11121429.


Impact of Procalcitonin Monitoring on Duration of Antibiotics in Patients With Sepsis and/or Pneumonia in a Community Hospital Setting.

Covington E, Eure S, Carroll D, Freeman C J Pharm Technol. 2021; 34(3):109-116.

PMID: 34861025 PMC: 6580727. DOI: 10.1177/8755122518756333.


References
1.
Moosig F, Csernok E, Reinhold-Keller E, Schmitt W, Gross W . Elevated procalcitonin levels in active Wegener's granulomatosis. J Rheumatol. 1998; 25(8):1531-3. View

2.
Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay M, Huber P, Tamm M . Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet. 2004; 363(9409):600-7. DOI: 10.1016/S0140-6736(04)15591-8. View

3.
Meisner M, Lohs T, Huettemann E, Schmidt J, Hueller M, Reinhart K . The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function. Eur J Anaesthesiol. 2001; 18(2):79-87. DOI: 10.1046/j.0265-0215.2000.00783.x. View

4.
Eto D, Lao C, DiToro D, Barnett B, Escobar T, Kageyama R . IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation. PLoS One. 2011; 6(3):e17739. PMC: 3056724. DOI: 10.1371/journal.pone.0017739. View

5.
Elenius V, Peltola V, Ruuskanen O, Yliharsila M, Waris M . Plasma procalcitonin levels in children with adenovirus infection. Arch Dis Child. 2011; 97(6):582-3. DOI: 10.1136/archdischild-2011-301308. View